Clinical Trials Directory

Trials / Completed

CompletedNCT03699488

Messaging Therapy for Depression and Anxiety: A Longitudinal Effectiveness Study

Asynchronous Messaging Therapy for Depression and Anxiety: A Longitudinal Study

Status
Completed
Phase
Study type
Observational
Enrollment
12,980 (actual)
Sponsor
Talkspace · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Therapies delivered via technology have been developed to improve accessibility, however, there is limited research regarding messaging therapy in particular, and none that we know of utilizing a longitudinal effectiveness design. The aim of this study was to investigate the overall effectiveness of messaging therapy, identify any contributors to its effectiveness, and to evaluate a dosage effect for this type of treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALpsychotherapy via asynchronous messageBehavioral psychotherapy delivered by asynchronous message using the Talkspace application

Timeline

Start date
2016-01-01
Primary completion
2018-02-01
Completion
2018-02-01
First posted
2018-10-09
Last updated
2019-02-06

Source: ClinicalTrials.gov record NCT03699488. Inclusion in this directory is not an endorsement.